跳至主要内容
临床试验/CTRI/2025/09/094700
CTRI/2025/09/094700尚未招募Unknown

A Clinical Study to Evaluate the Skin Brightening activity of Vitamin C Microneedle Serum Shot

Honasa Consumer Limited –(Brand – The Derma Co.)1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2025年9月23日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
36
试验地点
1
主要终点
1. Change in Dark spots & Pigmentation

研究概览

简要总结

A Single Blind one arm study

To evaluate the trial assigned to a regimen of investigational product

  1. Skin gloss-

  2. Anti PIgmentation

Gender: Male and female aged between18 to 50. Volunteers-36

Test Product: Vitamin C Microneedle Serum Shot Dose: 2-4 drops twice in a day Route of Administration: Topical

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)

入选标准

  • Gender: Male and female aged between18 to
  • Subject with dull skin.
  • Subject willing to give written informed consent
  • Women of child bearing potential must have a negative urine pregnancy test
  • Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE.
  • Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural or artificial) for the duration of the study.

排除标准

  • Subjects who are pregnant, breast feeding, or planning to become pregnant during the study
  • Volunteers with skin conditions such as eczema, psoriasis, etc
  • Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition.
  • Have open sore or open lesions in the treatment area
  • Have any condition that, in the opinion of the investigator, would confound the safety and efficacy assessments of the product.
  • Have participated in any interventional clinical trial in the previous 30 days.
  • Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents.
  • Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), including corticosteroids.
  • Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

结局指标

主要结局

1. Change in Dark spots & Pigmentation

时间窗: At T0min, T1hrs, T14days

2. Change in Skin Gloss

时间窗: At T0min, T1hrs, T14days

3. Change in Melanin Index

时间窗: At T0min, T1hrs, T14days

4. Change in skin lightness

时间窗: At T0min, T1hrs, T14days

5. Change in skin firmness

时间窗: At T0min, T1hrs, T14days

6. Change in skin hydration

时间窗: At T0min, T1hrs, T14days

7. Change in TEWL

时间窗: At T0min, T1hrs, T14days

8. Change in Smoothness

时间窗: At T0min, T1hrs, T14days

次要结局

  • SGA(At T14days)

研究者

发起方
Honasa Consumer Limited –(Brand – The Derma Co.)
申办方类型
Pharmaceutical industry-Indian
责任方
Principal Investigator
主要研究者

Dr Robin chugh

CCFT Laboratories

研究点 (1)

Loading locations...

相似试验